Merck & Co.
Search results
For 175 years, Pfizer has been a trusted partner in healthcare – discovering, developing, and delivering medical breakthroughs to prevent, treat, and cure some of the world’s most vexing conditions and diseases. Learn more about our history.
Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology.
As of April 2023, we had 33 clinical trials on-going in the UK, across 95 UK sites, involving 471 patients since the trials started. Download the 'Pfizer in the UK' fact sheet. Over 150 Pfizer medicines and vaccines are licensed for use in the UK. Our UK investment goes beyond our medicines.
Step inside the world of Pfizer and you’ll discover that every single person who works here plays an essential part in making breakthroughs that change patients’ lives. Read More Medicines Donations. We have been a proud supporter of International Health Partners (IHP) for around 15 years. Read More Working with Healthcare Professionals
Pfizer Inc. and BioNTech SE announced today they have begun an evaluation of the safety and immunogenicity of a third dose of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) to understand the effect of a booster on immunity against COVID-19 caused by the circulating and potential newly emerging SARS-CoV-2 variants.
Pfizer is one of the world's premier innovative biopharmaceutical companies, discovering, developing and providing over 150 different medicines and vaccines to help improve the lives of millions of people in the UK and around the world.
Vaccines work by preparing the body’s immune system with a defense against the pathogen. The virus or bacterium is recognized, neutralized, and destroyed, often before it can spread. Our Vaccine Research and Development scientists are working to extend the benefits of vaccines into new areas.
